sodium salicylate has been researched along with Drug-Induced Cochlear Toxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Lin, X; Liu, P; Qin, D; Qin, J; Su, J; Wei, F; Wei, T; Ye, W | 1 |
| Abd-Elhakim, YM; Abdel-Motal, SM; Beheiry, RR; Ibrahim, WM; Malhat, SM; Moselhy, AAA; Mostafa, HI; Said, EN | 1 |
2 other study(ies) available for sodium salicylate and Drug-Induced Cochlear Toxicity
| Article | Year |
|---|---|
Salicylate Induced GABAAR Internalization by Dopamine D1-Like Receptors Involving Protein Kinase C (PKC) in Spiral Ganglion Neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cells, Cultured; Disease Models, Animal; Female; Humans; Hydrazones; Male; Models, Animal; Neurons; Ototoxicity; Patch-Clamp Techniques; Primary Cell Culture; Protein Kinase C; Rats; Receptors, Dopamine D1; Receptors, GABA-A; Sodium Salicylate; Spiral Ganglion | 2021 |
Curcumin attenuates gentamicin and sodium salicylate ototoxic effects by modulating the nuclear factor-kappaB and apoptotic pathways in rats.
Topics: Animals; Apoptosis; Caspase 3; Curcumin; Gentamicins; NF-kappa B; Ototoxicity; Rats; Sodium Salicylate | 2022 |